Ipsc Derived Dopaminergic Neurons (Lrrk2 G2019S) is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
iPSC-Derived Dopaminergic Neurons (LRRK2 G2019S) are dopaminergic neurons generated from induced pluripotent stem cells carrying the LRRK2 G2019S mutation. These patient-derived neurons model Parkinson's disease pathogenesis with high fidelity. [@reinhardt2013]
Overview
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions. [@borgs2016]
Ipsc Derived Dopaminergic Neurons (Lrrk2 G2019S) is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
iPSC-Derived Dopaminergic Neurons (LRRK2 G2019S) are dopaminergic neurons generated from induced pluripotent stem cells carrying the LRRK2 G2019S mutation. These patient-derived neurons model Parkinson's disease pathogenesis with high fidelity. [@reinhardt2013]
Overview
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions. [@borgs2016]
Patient-derived neurons offer advantages over other models:
Human genetic background
Disease-relevant cell type
Age-appropriate cellular context
Cellular Characteristics
Dopaminergic Identity
These neurons express:
tyrosine hydroxylase (TH)
aromatic L-amino acid decarboxylase (AADC)
Dopamine transporter (DAT)
VMAT2
LRRK2 Pathology
LRRK2 G2019S neurons show:
Increased LRRK2 kinase activity
Enhanced autophosphorylation
Substrate hyperphosphorylation
Disease Phenotypes
Key pathological features include:
Reduced dopamine release
Increased spontaneous activity
Altered neuronal connectivity
Pathophysiological Mechanisms
Mitochondrial Dysfunction
LRRK2 G2019S neurons exhibit:
Impaired mitochondrial dynamics
Reduced mitochondrial membrane potential
Increased mitochondrial ROS
Protein Aggregation
These neurons demonstrate:
Enhanced alpha-synuclein phosphorylation
Increased aggregation propensity
Impaired autophagy
Oxidative Stress
Cellular stress markers:
Elevated ROS production
DNA damage accumulation
Altered antioxidant responses
Therapeutic Applications
Drug Screening
iPSC models enable:
Identification of LRRK2 inhibitors
Testing of neuroprotective compounds
Patient-stratified screening
Disease Mechanisms
These models reveal:
LRRK2-dependent pathways
Novel therapeutic targets
Biomarker discovery
Personalized Medicine
Patient-specific neurons allow:
Individual drug responses
Toxicity testing
Treatment optimization
Background
The study of Ipsc Derived Dopaminergic Neurons (Lrrk2 G2019S) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.